Literature DB >> 9222689

Hepatic dysfunction following cardiac surgery: determinants and consequences.

A Michalopoulos1, P Alivizatos, S Geroulanos.   

Abstract

BACKGROUND/AIMS: We prospectively studied the determinants, characteristics, and consequences of hepatic dysfunction in the early postoperative period following cardiac surgery.
METHODOLOGY: We examined 3041 adult patients, mean age 60.6 (+/- 8.9), with normal pre-operative liver function who consecutively underwent open heart surgery in a newly established Cardiac Surgery Center. Patients were divided into two groups; Group A included all patients who developed hepatic dysfunction, defined as the presence of jaundice associated with an elevated serum bilirubin above 3 mg/dl, in the early postoperative period. The control group included cardiac surgical patients who did not develop such dysfunction.
RESULTS: Hepatic dysfunction developed in 96 patients (3.2%). The affected patients consisted of 63 males and 33 females, mean age 60.8 (+/- 9.4). Determinants of hepatic dysfunction based on univariate analysis were sex, NYHA class, type of surgery, operative times, low cardiac output syndrome necessitating administration of inotropic agents and/or IABP usage, cardiac arrest, presence of hematomas, and number of blood transfusions. Patients with hepatic dysfunction required prolonged mechanical ventilation, stayed longer in the ICU (and in the hospital) and experienced a much higher mortality rate (11.4%) compared to the control group (p = 0.001).
CONCLUSION: Although the pathogenesis of hepatic dysfunction seems to be multifactorial, liver cell damage due to decreased perioperative hepatic flow and increased bilirubin load seem to be of critical importance. Early postoperative hepatic dysfunction resulted in increased morbidity and mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9222689

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

Review 1.  The prognostic significance of postoperative hyperbilirubinemia in cardiac surgery: systematic review and meta-analysis.

Authors:  Dev Raveendran; Jahan C Penny-Dimri; Reny Segal; Julian A Smith; Mark Plummer; Zhengyang Liu; Luke A Perry
Journal:  J Cardiothorac Surg       Date:  2022-05-26       Impact factor: 1.522

2.  Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study.

Authors:  Yong An; Ying-Bin Xiao; Qian-Jin Zhong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

3.  Off-pump coronary artery bypass grafting in a patient with liver cirrhosis.

Authors:  Taira Yamamoto; Kenji Takazawa; Akifusa Hariya; Noboru Ishikawa; Shizuyuki Dohi; Satoshi Matsushita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-12

4.  Results of cardiac surgery in advanced liver cirrhosis.

Authors:  Naoto Morimoto; Kenji Okada; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-01

5.  Renal and abdominal visceral complications after open aortic surgery requiring supra-renal aortic cross clamping.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Young-Nam Roh; Yang Jin Park; Dong-Ik Kim; Young-Wook Kim
Journal:  J Korean Surg Soc       Date:  2012-08-27

6.  Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy.

Authors:  K K Hosotsubo; M Nishimura; S Nishimura
Journal:  Crit Care       Date:  2000-03-27       Impact factor: 9.097

7.  Cardiopulmonary Bypass Ischemic Hepatitis Reported in Five Patients.

Authors:  Telma A Damasceno; Adilson Scorzoni; Fernando Chahud; Alfredo José Rodrigues; Walter Vilella de Andrade Vicente; Paulo Roberto Barbosa Evora
Journal:  Braz J Cardiovasc Surg       Date:  2016 Jul-Sep

8.  Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study.

Authors:  Xiaolan Chen; Ming Bai; Lijuan Zhao; Yangping Li; Yan Yu; Wei Zhang; Feng Ma; Shiren Sun; Xiangmei Chen
Journal:  J Cardiothorac Surg       Date:  2020-07-28       Impact factor: 1.637

9.  Hyperbilirubinaemia after cardiac surgery: the point of no return.

Authors:  Mina Farag; Gabor Veres; Gabor Szabó; Arjang Ruhparwar; Matthias Karck; Rawa Arif
Journal:  ESC Heart Fail       Date:  2019-05-16

10.  Time to peak bilirubin concentration and advanced AKI were associated with increased mortality in rheumatic heart valve replacement surgery patients with severe postoperative hyperbilirubinemia: a retrospective cohort study.

Authors:  Xiaolan Chen; Ming Bai; Lijuan Zhao; Yan Yu; Yuan Yue; Shiren Sun; Xiangmei Chen
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.